{"id":"AGY-ST-HEALTH-BOARDS-028","kind":"order","level":"sector-regulator","jurisdiction":"California Department of Consumer Affairs, Director (California State Board of Pharmacy); State level","state":"CA","metro":"","industry":"","agency":"ST-HEALTH-BOARDS","eco":"","issuer":"Kimberly Kirchmeyer, Director, Department of Consumer Affairs","authority":"Executive Order N-39-20; Cal. Gov\u0027t Code § 8571","instrument":"DCA Waiver DCA-20-14, Order Waiving Restrictions on Pharmacists Ordering and Collecting Specimens for COVID-19 Tests","title":"Order Waiving Restrictions on Pharmacists Ordering and Collecting Specimens for COVID-19 Tests","dateIssued":"2020-05-12","effective":"2020-05-12 (effective immediately)","end":"Terminates 60 days from the date of the order unless extended; extended by DCA-20-34 and superseded by DCA-20-45 (Ex. 031, Aug. 25, 2020)","startDate":"2020-05-12","endDate":"2020-08-25","quarters":["2020Q2","2020Q3"],"types":["HC","OTHER"],"addressees":["California pharmacists","pharmacies"],"clause":"Pursuant to Executive Order N-39-20, the Director waives Business and Professions Code section 4051, subdivision (b) and section 4052, subdivision (a)(12), to the extent those provisions would otherwise prohibit pharmacists from ordering or otherwise authorizing tests for the presence of the virus SARS-CoV-2 (\u0027COVID 19 tests\u0027) in [patients, and from collecting specimens]. The waiver is subject to the following conditions: The test is authorized by the United States Food and Drug Administration (FDA) and is processed in a public health, commercial, or clinical laboratory pursuant to state and federal rules; and,... This order is effective immediately, and may be amended from time to time in the discretion of the Director. This order terminates 60 days from the date of the order, unless further extended.","enforcement":"Conditions of the waiver; Bus. \u0026 Prof. Code § 4301 (pharmacy discipline)","functions":["DX diagnostics (pharmacies as COVID-19 specimen-collection sites)","SC pharmacy operations","HR scope of practice","CB patients"],"notes":"Pharmacy testing authorization (California); parallel to Florida DOH EO 20-006 (Ex. 005)","sourceUrl":"https://www.dca.ca.gov/licensees/pharmacists_covid19_tests.pdf","snapshot":"","fileExists":true,"fileBytes":484520,"grade":"primary","character":"","description":"","collection":"AGY-ST-HEALTH-BOARDS","url":"/library/AGY-ST-HEALTH-BOARDS-028","exhibitUrl":"/exhibit/AGY-ST-HEALTH-BOARDS-028","citation":"Kimberly Kirchmeyer, Director, Department of Consumer Affairs, DCA Waiver DCA-20-14, Order Waiving Restrictions on Pharmacists Ordering and Collecting Specimens for COVID-19 Tests (May 12, 2020) (Ex. AGY-ST-HEALTH-BOARDS-028)","stateName":"California","related":["AGY-ST-HEALTH-BOARDS-024","AGY-ST-HEALTH-BOARDS-025","AGY-ST-HEALTH-BOARDS-026","AGY-ST-HEALTH-BOARDS-027","AGY-ST-HEALTH-BOARDS-029","AGY-ST-HEALTH-BOARDS-030","AGY-ST-HEALTH-BOARDS-023","AGY-ST-HEALTH-BOARDS-022","AGY-ST-HEALTH-BOARDS-020","AGY-ST-HEALTH-BOARDS-021"]}